Document is current

Any future updates will be listed below

Critical assessment of anti-amyloid-β monoclonal antibodies effects in Alzheimer’s disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness

Crossref DOI link: https://doi.org/10.1038/s41598-024-75204-8

Published Online: 2024-10-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark